The Department of Biomedical and Pharmaceutical Sciences at Idaho State University is seeking a motivated PhD-level graduate student to join the medicinal chemistry team led by Dr. Sri Nath Pashikanti for Fall 2026. The research group focuses on synthetic medicinal chemistry, enzymology, and in vivo studies, with current efforts aimed at developing and screening small molecules targeting ceramide metabolizing enzymes, which have anticancer properties. Students will receive comprehensive training in synthetic chemistry, protein biochemistry, and bioanalytical chemistry, and will have opportunities to participate in cutting-edge research in drug discovery and pharmaceutical sciences.

Applicants should have a recent MS in Chemistry, Biochemistry, or Pharmacy with a medicinal chemistry background, or an M.Sc. in Organic Chemistry with a strong interest in pursuing doctoral studies. The program requires a minimum GPA of 3.0, a GRE combined score of at least 300 with at least 50th percentile in one section, and for international students, an IELTS score of 6.5 or TOEFL iBT score of 80. Application materials include a resume/CV, personal statement, three letters of recommendation, and official transcripts. The department spans both the Pocatello and Meridian campuses, offering a collaborative environment with faculty expertise in drug discovery, pharmacology, pharmaceutical sciences, and biomedical informatics.

While specific funding details are not provided, graduate students typically receive training and may be eligible for assistantships. The application deadline for Fall 2026 is April 1, 2026. Interested candidates should apply online via the ISU application portal and ensure all requirements are met. For more information, visit the department and research group pages or contact Dr. Pashikanti directly.